This entry passed through the Full-Text RSS service - if this is your content and you're reading it on someone else's site, please read the FAQ at http://ift.tt/jcXqJW.
Wednesday 11 Mar 2015 - 15:51 Makkah mean time-20-5-1436  Internet/Image Moscow (IINA) – Clinical tests are underway in Russia on medicines to combat cancer and tick borne encephalitis, following studies on lactaptin – human breast milk.
The drug, unmatched worldwide, was created by scientists at the Siberian Branch of Russian Academy of Sciences. A special center for conducting the clinical trials on the medication, which expected to cure cancer and tick borne diseases, was established in the city of Novosibirsk.
In statements carried by Radio Russia and published by Qatar News Agency (QNA) on Wednesday, Valentin Vlasovs, director of the Siberian Institute of Chemical Biology and Fundamental Medicine, said: "It is a new product name “Laktoptin” made from mother's milk, which is necessary to routinely maintain the count of cells and their functions in multicellular objects, as well as to expel the infected and cancer cells”.
He added that the treatment for diseases caused by tick bites, is a special antibodies product, whose effectiveness is greater than "Immunoglobulin", noting that its clinical test is likely to be completed before that of the anti-cancer medication.
AB/IINA
|
No comments:
Post a Comment